Please select the option that best describes you:
What is your approach between choosing lumasiran or nedosiran for patients with primary hyperoxaluria type 1?
Answer from: at Academic Institution
At this time, the available evidence suggests both agents are more or less equally effective for PH1 in reducing urinary oxalate excretion over many months. Thus I would be comfortable prescribing either for a PH1 patient.
Sign in or Register to read more
Answer from: at Community Practice
Great answer about a challenging question about therapeutic options with primary hyperoxaluria.